Related Experiment Video

Updated: May 17, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Impact of epidermal growth factor receptor (EGFR) cell surface expression levels on effector mechanisms of EGFR

Stefanie Derer1, Philip Bauer, Stefan Lohse

  • 1Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, Christian-Albrechts-University and University Hospital Schleswig-Holstein, 24105 Kiel, Germany.

Journal of Immunology (Baltimore, Md. : 1950)
|October 27, 2012
PubMed

Insights

Tumor cell expression of epidermal growth factor receptor (EGFR) impacts how EGFR monoclonal antibodies (mAbs) work. Higher EGFR levels enhance Fc-mediated tumor cell killing, while Fab-mediated effects decrease with more EGFR.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Epidermal growth factor receptor (EGFR) is a key target in cancer therapy.
  • EGFR monoclonal antibodies (mAbs) show efficacy, but their mechanisms of action (MoAs) relative to EGFR expression are unclear.
  • Previous studies link EGFR levels to therapeutic response, but not specific MoAs.

Purpose of the Study:

  • To investigate how varying epidermal growth factor receptor (EGFR) expression levels affect the mechanisms of action (MoAs) of EGFR monoclonal antibodies (mAbs).
  • To determine the correlation between EGFR expression and both Fab- and Fc-mediated MoAs.
  • To provide insights into optimizing EGFR mAb-based cancer therapies.

Main Methods:

  • Stable transfection of BHK-21 cells to express diverse EGFR levels, quantified by immunofluorescence and immunohistochemistry.
  • Systematic investigation of Fab- and Fc-mediated MoAs using these engineered cells and clinical tumor samples.
  • Assessment of Ab-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).
  • Validation using RNA interference-induced knockdown and an independent panel of human tumor cell lines.

Main Results:

  • A negative correlation was observed between EGFR levels and the potency of Fab-mediated MoA.
  • Ab-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) positively correlated with EGFR expression levels.
  • Higher EGFR expression and mAb concentrations were required for significant tumor cell killing via polymorphonuclear cell-mediated ADCC and CDC compared to mononuclear cell-mediated ADCC.
  • These findings were consistent across different tumor cell lines and confirmed by knockdown experiments.

Conclusions:

  • EGFR expression levels significantly influence the distinct mechanisms of action of EGFR mAbs.
  • Fc-mediated MoAs, including ADCC and CDC, are enhanced by higher EGFR expression.
  • EGFR expression patterns may dictate the dominant MoA, impacting therapeutic outcomes for EGFR mAb treatments.

More Related Videos

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy09:16

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy

Published on: September 11, 2015

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...